Skip to main content

Pharvaris

Community Commitment

Pharvaris is committed to strong collaboration with patient organizations, as well as with experts in the bradykinin-mediated angioedema (AE-BK) community, and supports the work undertaken on behalf of those living with AE-BK.

resources

For more support and resources please visit:

We invite healthcare professionals and those living with hereditary angioedema (HAE) to explore Pharvaris’ deflateHAE where real stories and insights highlight what living with HAE can be like.

Living with bradykinin-mediated angioedema (AE-BK)

Living with AE-BK can mean living with attacks that are unpredictable in frequency, location, timing, duration, and severity, imposing significant burden on emotional and physical wellbeing. AE-BK can affect all genders, ages, and ethnic groups.

Due to its rarity and overlap of symptoms with other conditions, AE-BK can be frequently under-recognized and/or misdiagnosed, especially in cases without family history.

How common is bradykinin-mediated angioedema?

HAE is a rare disease that is estimated to impact approximately 1 in 50,000 people:

USA ~7,000

Europe ~15,000

Acquired angioedema due to C1INH deficiency (AAE-C1INH) is an ultra-rare disease that is estimated to impact approximately 1 in 500,000 people:

USA ~700 people

Europe ~1,500 people
References

Banerji A, et al. Ann Allergy Asthma Immunol. 2020. | Betschel S, et al. Allergy Asthma Clin Immunol. 2019. | Bork K, et al. Am J Gastroenterol. 2006. | Bork K, et al. Am J Med. 2006. | Busse P and Kaplan A. J Allergy Clin Immunol Pract. 2022. | Caballero T, et al. J Investig Allergol Clin Immunol. 2016. | de Lange M, et al. J Allergy Clin Immunol. 2025. | Farkas H, et al. Allergy. 2017. | Food and Drug Administration. "The Voice of the Patient." 2017. | Frank MM, et al. Immunol Allergy Clin North Am. 2006. | Huang SW. Allergy Asthma Proc. 2004. | Johnston DT and Smith RC. Allergy Asthma Proc. 2020. | Lo SH, et al. Pharmacoecon Open. 2022. | Longhurst HJ and Bork K. Br J Hosp Med (Lond). 2019. | Longhurst H and Bygum A. Clin Rev Allergy Immunol. 2016. | Longhurst H and Cicardi M. Lancet. 2012. | Lumry WR, et al. Allergy Asthma Proc. 2010. | Lumry WR. Am J Manag Care. 2013. | Lumry WR and Settipane RA. Allergy Asthma Proc. 2020. | Magerl M, at al. Clin Transl Allergy. 2023. | Maurer M, et al. Allergy. 2022. | Mendivil J, et al. Orphanet J Rare Dis. 2021. | Pagnier A, et al. Pediatr Allergy Immunol. 2024. | Riedl MA, et al. Allergy Asthma Proc. 2021. | Riedl MA, et al. J Allergy Clin Immunol Pract. 2023. | Savarese L, et al. Allergy Asthma Proc. 2021. | Sylvestre S, et al. J Allergy Clin Immunol Pract. 2021. | Vazquez DO, et al. World Allergy Organ J. 2026. | Zanichelli A, et al. Ann Allergy Asthma Immunol. 2016. | Zotter Z, et al. Orphanet J Rare Dis. 2014. | Zuraw BL, et al. Clin Rev Allergy Immunology. 2025.